Voltage-gated sodium channels as molecular targets for neuropathic pain

Drug Development Research

Volumn 67, Issue 4, 2006, Pages 360-375

  Priestley, Tony ^a   Hunter, John C ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Neuropathic; Pain; Sodium channel

Indexed keywords

AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; FLECAINIDE; LAMOTRIGINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEXILETINE; OXCARBAZEPINE; PHENYTOIN; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; TOCAINIDE; TOPIRAMATE; VOLTAGE GATED SODIUM CHANNEL;

ATAXIA; CARDIOTOXICITY; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; DIZZINESS; FATIGUE; HEART DISEASE; HUMAN; INTRACTABLE PAIN; LANGUAGE DISABILITY; LEUKOPENIA; MEMORY DISORDER; MOOD DISORDER; NAUSEA; NERVE CELL MEMBRANE; NERVE EXCITABILITY; NEUROPATHIC PAIN; NONHUMAN; PSYCHOMOTOR DISORDER; REVIEW; SENSORY NERVE; SIDE EFFECT; SIGNAL TRANSDUCTION; SOMNOLENCE; SPEECH DISORDER; TINNITUS; TRIGEMINUS NEURALGIA; VOMITING; WEIGHT REDUCTION;

EID: 33747797348     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20100     Document Type: Review

References (221)

1. Abdulla FA, Smith PA. 2001. Axotomy- and autotomy-induced changes in the excitability of rat dorsal root ganglion neurons. J Neurophysiol 85:630-643.
2. Abram SE, Yaksh TL. 1994. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 80:383-391; discussion 25A.
3. Akopian AN, Sivilotti L, Wood JN. 1996. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379:257-262.
4. Amaya F, Decosterd I, Samad TA, Plumpton C, Tate S, Mannion RJ, Costigan M, Woolf CJ. 2000, Diversity of expression of the sensory neuron-specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2. Mol Cell Neurosci 15:331-342.
5. Anand P. 2004. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 146:477-492.
6. Arbuckle JB, Docherty RJ. 1995. Expression of tetrodotoxin-resistant sodium channels in capsaicin-sensitive dorsal root ganglion neurons of adult rats. Neurosci Lett 185:70-73.
7. Arner S, Lindblom U, Meyerson BA, Molander C. 1990. Prolonged relief of neuralgia after regional anesthetic blocks. A call for further experimental and systematic clinical studies. Pain 43:287-297.
8. Bach FW, Jensen TS, Kastrup J, Stigsby B, Dejgard A. 1990. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 40:29-34.
9. Backonja MM. 1994. Local anesthetics as adjuvant analgesics. J Pain Symptom Manage 9:491-499.
10. Baker M, Bostock H. 1992. Ectopic activity in demyelinated spinal root axons of the rat. J Physiol (Lond) 451:539-552.
11. Balser JR, Nuss HB, Romashko DN, Marban E, Tomaselli GF. 1996. Functional consequences of lidocaine binding to slow-inactivated sodium channels. J Gen Physiol 107:643-658.
12. Ben-Menachem E, Axelsen M, Johanson EH, Stagge A, Smith U. 2003. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 11:556-562.
13. Beydoun A, Kobetz SA, Carrazana EJ. 2004. Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. Clin J Pain 20:174-178.
14. Black JA, Dib-Hajj S, McNabola K, Jeste S, Rizzo MA, Kocsis JD, Waxman SG. 1996. Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. Brain Res Mol Brain Res 43:117-131.
15. Black JA, Liu S, Tanaka M, Cummins TR, Waxman SG. 2004. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 108:237-247.
16. Blom S. 1962. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). Lancet 1:839-840.
17. Bonifacio MJ, Sheridan RD, Parada A, Cunha RA, Patmore L, Soares-da-Silva P. 2001. Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine. Epilepsia 42:600-608.
18. Boucher TJ, Okuse K, Bennett DL, Munson JB, Wood JN, McMahon SB. 2000. Potent analgesic effects of GDNF in neuropathic pain states. Science 290:124-127.
19. Brock JA, McLachlan EM, Belmonte C. 1998. Tetrodotoxin-resistant impulses in single nociceptor nerve terminals -in guinea-pig cornea. J Physiol (Lond) 512:211-217.
20. Bucknill AT, Coward K, Plumpton C, Tate S, Bountra C,. Birch R, Sandison A, Hughes SP, Anand P. 2002. Nerve fibers in lumbar spine structures and injured spinal roots express the sensory neuron-specific sodium channels SNS/PN3 and NaN/SNS2. Spine 27:135-140.
21. Burchiel KJ. 1980a. Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg 53:674-683.
22. Burchiel KJ. 1980b. Ectopic impulse generation in focally demyelinated trigeminal nerve. Exp Neurol 69:423-429.
23. Burchiel KJ, Russell LC, Lee RP, Sima AA. 1985. Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain. Diabetes 34:1210-1213.
24. Burgess SE, Gardell LR, Ossipov MH, Malan TP Jr, Vanderah TW, Lai J, Porreca F. 2002. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci 22:5129-5136.
25. Calvin WH, Devor M, Howe JF. 1982. Can neuralgias arise from minor demyelination? Spontaneous firing, mechanosensitivity, and afterdischarge from conducting axons. Exp Neurol 75:755-763.
26. Campbell FG, Graham JG, Zilkha KJ. 1966. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 29:265-267.
27. Campbell JN, Raja SN, Meyer RA, Mackinnon SE. 1988. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 32:89-94.
28. Campero M, Serra J, Marchettini P, Ochoa JL. 1998. Ectopic impulse generation and autoexcitation in single myelinated afferent fibers in patients with peripheral neuropathy and positive sensory symptoms. Muscle Nerve 21:1661-1667.
29. + channels: local anesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacol Sci 8:57-65.
30. Catterall WA. 1999. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adv Neurol 79:441-456.
31. Catterall WA. 2000. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26:13-25.
32. Catterall WA. 2002. Molecular mechanisms of gating and drug block of sodium channels. Novartis Found Symp 241:206-218; discussion 218-232.
33. Catterall WA, Goldin AL, Waxman SG. 2003. International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels. Pharmacol Rev 55:575-578.
34. Chabal C, Russell LC, Burchiel KJ. 1989. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 38:333-338.
35. Chabal C, Jacobson L, Mariano A, Chaney E, Britell CW. 1992a. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 76:513-517.
36. Chabal C, Jacobson L, Russell LC, Burchiel KJ. 1992b. Pain response to perineuromal injection of normal saline, epinephrine, and lidocaine in humans. Pain 49:9-12.
37. Chadda VS, Mathur MS. 1978. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 26:403-406.
38. Chaplan SR, Bach FW, Shafer SL, Yaksh TL. 1995. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology 83:775-785.
39. Chapman V, Suzuki R, Dickenson AH. 1998. Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5-L6. J Physiol (Lond) 507:881-894.
40. Cheung H, Kamp D, Harris E. 1992. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107-112.
41. Chevrier P, Vijayaragavan K, Chahine M. 2004. Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine. Br J Pharmacol 142:576-584.
42. Chul Han H, Hyun Lee D, Mo Chung J. 2000. Characteristics of ectopic discharges in a rat neuropathic pain model. Pain 84:253-261.
43. Coggeshall RE, Tate S, Carlton SM. 2004. Differential expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 in normal and inflamed rats. Neurosci Lett 355:45-48.
44. Courtney KR, Etter EF. 1983. Modulated anticonvulsant block of sodium channels in nerve and muscle. Eur J Pharmacol 88:1-9.
45. Covino BG, Wildsmith J. 1998. Clinical pharmacology of local anesthetic agents. In: Cousins MJ, Bridenbaugh PO, editors. Neural blockade in clinical' anesthesia and management of pain. 3 ed. Philadelphia: Lippencott-Raven. p 97-128.
46. Coward K, Plumpton C, Facer P, Birch R, Carlstedt T, Tate S, Bountra C, Anand P. 2000. Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states. Pain 85:41-50.
47. Cummins TR, Waxman SG. 1997. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci 17:3503-3514.
48. Cummins TR, Howe JR, Waxman SG. 1998. Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 18:9607-9619.
49. Cummins TR, Dib-Hajj SD, Waxman SG. 2004. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 24:8232-8236.
50. De Luca A, Natuzzi F, Desaphy JF, Loni G, Lentini G, Franchini C, Tortorella V, Camerino DC. 2000. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels. Mol Pharmacol 57:268-277.
51. Decosterd I, Ji RR, Abdi S, Tate S, Woolf CJ. 2002. The pattern of expression of the voltage-gated sodium channels Na(v)1.8 and Na(v)1.9 does not change in uninjured primary sensory neurons in experimental neuropathic pain models. Pain 96:269-277.
52. Dejgard A, Petersen P, Kastrup J. 1988. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1:9-11.
53. Devor M, Seltzer Z. 2000. Pathophysiology of damaged nerves in relation to chronic pain. In: Wall P, Melzack R, editors. Textbook of pain. 4th ed. London: Churchill Livingstone. p 129-164.
54. Devor M, Wall P, Catalan N. 1992. Systemic lidocaine silences ectopic neuroma discharge and DRG discharge without blocking nerve conduction. Pain 48:261-268.
55. Devor M, Govrin-Lippmann R, Angelides K. 1993. Na+ channel accumulation in peripheral mammalian axons and changes following nerve injury and neuroma formation. J Neurosci 13:1976-1992.
56. Dib-Hajj S, Black JA, Felts P, Waxman SG. 1996. Down-regulation of transcripts for Na channel alpha-SNS in spinal sensory neurons following axotomy. Proc Natl Acad Sci USA 93:14950-14954.
57. Dib-Hajj S, Black JA, Cummins TR, Waxman SG. 2002. NaN/Nav1.9: a sodium channel with unique properties. Trends Neurosci 25:253-259.
58. Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG. 1998. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci USA 95:8963-8968.
59. Dib-Hajj SD, Fjell J, Cummins TR, Zheng Z, Fried K, LaMotte R, Black JA, Waxman SG. 1999. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 83:591-600.
60. Dietrich PS, McGivern JG, Delgado SG, Koch BD, Eglen RM, Hunter JC, Sangameswaran L. 1998. Functional analysis of a voltage-gated sodium channel and its splice variant from rat dorsal root ganglia. J Neurochem 70:2262-2272.
61. Djouhri L, Fang X, Okuse K, Wood JN, Berry CM, Lawson SN. 2003a. The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol 550:739-752.
62. Djouhri L, Newton R, Levinson SR, Berry CM, Carruthers B, Lawson SN. 2003b. Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein. J Physiol 546:565-576.
63. Dugandzija-Novakovic S, Koszowski A, Levinson S, Shrager P. 1995. Clustering of Na+ channels and node of Ranvier formation in remyelinating axons. J Neurosci 15:492-503.
64. Edwards W, Habib F, Burney R, Begin G. 1985. Intravenous lidocaine in the management of various chronic pain states. Reg Anesth 10:1-6.
65. Eisenberg E, Alon N, Yarnitsky D, Ishay A, Daoud D. 1996. Lamotriginie for the treatment of painful diabetic neuropathy. Canada. p 372.
66. Eliav E, Benoliel R, Tal M. 2001. Inflammation with no axonal damage of the rat saphenous nerve trunk induces ectopic discharge and mechanosensitivity in myelinated axons. Neurosci Lett 311:49-52.
67. Elliott AA, Elliott JR. 1993. Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J Physiol 463:39-56.
68. England JD, Gamboni F, Levinson SR, Finger TE. 1990. Changed distribution of sodium channels along demyelinated axons. Proc Natl Acad Sci USA 87:6777-6780.
69. England JD, Happel LT, Kline DG, Gamboni F, Thouron CL, Liu ZP, Levinson SR. 1996. Sodium channel accumulation in humans with painful neuromas. Neurology 47:272-276.
70. Fang X, Djouhri L, Black JA, Dib-Hajj SD, Waxman SG, Lawson SN. 2002. The presence and role of the tetrodotoxin-tesistant sodium channel Na(v)1.9 (NaN) in nociceptive primary afferent neurons. J Neurosci 22:7425-7433.
71. Felts PA, Yokoyama S, Dib-Hajj S, Black JA, Waxman SG. 1997. Sodium channel alpha-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): different expression patterns in developing rat nervous system. Brain Res Mol Brain Res 45:71-82.
72. Ferrante FM, Paggioli J, Cherukuri S, Arthur GR. 1996. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 82:91-97.
73. Finnerup NB, Gottrup H, Jensen TS. 2002. Anticonvulsants in central pain. Expert Opin Pharmacother 3:1411-1420.
74. Fitton A, Goa KL. 1995. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Drugs 50:691-713.
75. Fjell J, Hjelmstrom P, Hormuzdiar W, Milenkovic M, Aglieco F, Tyrrell L, Dib-Hajj S, Waxman S, Black J. 2000. Localization of the tetrodotoxin-resistant sodium channel NaN in nociceptors. Neuroreport 11:199-202.
76. Fletcher D, Le Corre P, Guilbaud G, Le Verge R. 1997. Antinociceptive · effect of bupivacaine encapsulated in poly(D,L)-lactide-co-glycolide microspheres in the acute inflammatory pain model of carrageenin-injected rats. Anesth Analg 84:90-94.
77. Galer B, Harle J, Rowbotham M. 1996. Response to intravenous lidocaine infusion predictes subsequent response to oral mexilitine: a prospective study. J Pain Symp Manage 12:161-167.
78. Galer BS, Miller KV, Rowbotham MC. 1993. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology 43:1233-1235.
79. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. 2002. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 18:297-301.
80. Gilron I, Booher SL, Rowan JS, Max MB. 2001. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol 24:109-112.
81. Gold MS, Weinreich D, Kim CS, Wang R, Treanor J, Porreca F, Lai J. 2003. Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain. J Neurosci 23:158-166.
82. Goldin AL. 2001. Resurgence of sodium channel research. Annu Rev Physiol 63:871-894.
83. Govrin-Lippmann R, Devor M. 1978. Ongoing activity in severed nerves: source and variation with time. Brain Res 159:406-410.
84. Gracely RH, Lynch SA, Bennett GJ. 1992. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 51:175-194.
85. Grieco TM, Malhotra JD, Chen C, Isom LL, Raman IM. 2005. Open-channel block by the cytoplasmic tail of sodium channel [beta]4 as a mechanism for resurgent sodium current. Neuron 45:233-244.
86. Grosskreutz J, Quasthoff S, Kuhn M, Grafe P. 1996. Capsaicin blocks tetrodotoxin-resistant sodium potentials and calcium potentials in unmyelinated C fibres of biopsied human sural nerve in vitro. Neurosci Letters 208:49-52.
87. Hains BC, Klein JP, Saab CY, Craner MJ, Black JA, Waxman SG. 2003. Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 23:8881-8892.
88. Han CH, Lee DH, Chung JM. 2000. Characteristics of ectopic discharges in a rat neuropathic pain model. Pain 84:253-261.
89. Harbison J, Dennehy F, Keating D. 1997. Lamotrigine for pain with hyperalgesia. Ir Med J 90:56.
90. Hedley LR, Martin B, Waterbury LD, Clarke DE, Hunter JC. 1995. A comparison of the action of mexiletine and morphine in rodent models of acute and chronic pain. Proc West Pharmacol Soc 38:103-104.
91. Herzog RI, Cummins TR, Ghassemi F, Dib-Hajj SD, Waxman SG. 2003. Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons. J Physiol 551:741-750.
92. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ. 1997. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324:153-160.
93. Ichimata M, Kitano T, Ikebe H, Iwasaka H, Noguchi T 2001. Flecainide reverses neuropathic pain and suppresses ectopic nerve discharge in rats. Neuroreport 12:1869-1873.
94. Isom LL. 2000. Cellular and molecular biology of sodium channel beta-subunits: therapeutic implications for pain? Am J Physiol Gastrointest Liver Physiol 278:G349-G353.
95. Isom LL. 2002. Beta subunits: players in neuronal hyperexcitability? Novartis Found Symp 241:124-138; discussion 138-143, 226-232.
96. Isom LL, De Jongh KS, Catterall WA. 1994. Auxiliary subunits of voltage-gated ion channels. Neuron 12:1183-1194.
97. Isom LL, Scheuer T, Brownstein AB, Ragsdale DS, Murphy BJ, Catterall WA. 1995. Functional co-expression of the beta 1 and type IIA alpha subunits of sodium channels in a mammalian cell line. J Biol Chem 270:3306-3312.
98. Jett MF, McGuirk J, Waligora D, Hunter JC. 1997. The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain 69:161-169.
99. Jiang Y, Lee A, Chen J, Ruta V, Cadene M, Chait BT, MacKinnon R. 2003. X-ray structure of a voltage-dependent K+ channel. Nature 423:33-41.
100. Kajander KC, Wakisaka S, Bennett GJ. 1992. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci Lett 138:225-228.
101. Kastrup J, Petersen P, Dejgard A, Angelo HR, Hilsted J. 1987. Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy? Pain 28:69-75.
102. Kerr BJ, Souslova V, McMahon SB, Wood JN. 2001. A role for the TTX-resistant sodium channel Nav 1.8 in NGF-induced hyperalgesia, but not neuropathic pain. Neuroreport 12:3077-3080.
103. Kerr NC, Holmes FE, Wynick D. 2004. Novel isoforms of the sodium channels Nav1.8 and Nav1.5 are produced by a conserved mechanism in mouse and rat. J Biol Chem 26:26.
104. Khasar SG, Gold MS, Levine JD. 1998. A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat. Neurosci Lett 256:17-20.
105. Khodorova A, Meissner K, Leeson S, Strichartz GR. 2001. Lidocaine selectively blocks abnormal impulses arising from noninactivating Na channels. Muscle Nerve 24:634-647.
106. Killian JM, Fromm GH. 1968. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol 19:129-136.
107. Kim CH, Oh Y, Chung JM, Chung K. 2001. The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation. Brain Res Mol Brain Res 95:153-161.
108. Kim CH, Oh Y, Chung JM, Chung K. 2002. Changes in three subtypes of tetrodotoxin sensitive sodium channel expression in the axotomized dorsal root ganglion in the rat. Neurosci Lett 323:125-128.
109. Kingery WS. 1997. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73:123-139.
110. Koch BD, Faurot GF, McGuirk JR, Clarke DE, Hunter JC. 1996. Modulation of mechano-hyperalgesia by clinically effective analgesics in rats with a peripheral mononeuropathy. Analgesia 2:157-164.
111. Koltzenburg M, Torebjork HE, Wahren LK. 1994a. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 117:579-591.
112. Koltzenburg M, Torebjork HE, Wahren LK. 1994b. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 117:579-591.
113. Kondratiev A, Tomaselli GF. 2003. Altered gating and local anesthetic block mediated by residues in the I-S6 and II-S6 transmembrane segments of voltage-dependent Na+ channels. Mol Pharmacol 64:741-752.
114. Koninck Y, Henry J. 1991. Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by-noxious stimulation. PNAS 88:11344-11348.
115. Kretschmer T, Happel LT, England JD, Nguyen DH, Tiel RL, Beuerman RW, Kline DG. 2002. Accumulation of PN1 and PN3 sodium channels in painful human neuroma-evidence from immunocytochemistry. Acta Neurochir (Wien) 144:803-810.
116. Kuo CC, Chen RS, Lu L, Chen RC. 1997. Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications. Mol Pharmacol 51:1077-1083.
117. Kuroda Y, Miyamoto K, Tanaka K, Maeda Y, Ishikawa J, Hinata R, Otaka A, Fujii N, Nakagawa T. 2000. Interactions between local anesthetics and Na+ channel inactivation gate peptides in phosphatidylserine suspensions as studied by 1H-NMR spectroscopy. Chem Pharm Bull (Tokyo) 48:1293-1298.
118. Lai J, Hunter JC, Ossipov MH, Porreca F. 2000. Blockade of neuropathic pain by antisense targeting of tetrodotoxin-resistant sodium channels in sensory neurons. Methods Enzymol 314:201-213.
119. Lai J, Gold MS, Kim CS, Bian D, Ossipov MH, Hunter JC, Porreca F. 2002. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain 95:143-152.
120. Laird JM, Souslova V, Wood JN, Cervero F. 2002. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J Neurosci 22:8352-8356.
121. Laughlin TM, Tram KV, Wilcox GL, Birnbaum AK. 2002. Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. J Pharmacol Exp Ther 302:1168-1175.
122. Leach MJ, Marden CM, Miller AA. 1986. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490-497.
123. Lee TH, Wang CJ, Wu PC, Buerkle H, Lin SH, Yang LC. 2002. The thermal and mechanical anti-hyperalgesic effects of pre- versus post-intrathecal treatment with lamotrigine in a rat model of inflammatory pain. Life Sci 70:3039-3047.
124. Levine JD, Reichling DB. 2000. Peripheral mechanisms in inflammatory pain. In: Wall PD, Melzack R, editors. Textbook of pain. 4th ed. London: Churchill Livingstone. p 59-84.
125. Lewin GR, Barde YA. 1996. Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317.
126. Lindia JA, Kohler MG, Martin WJ, Abbadie C. 2005. Relationship between sodium channel Na(V)1.3 expression and neuropathic pain behavior in rats. Pain 29:29.
127. Lindstrom P, Lindblom U. 1987. The analgesic effect of tocainide in trigeminal neuralgia. Pain 28:45-50.
128. Liu CN, Wall PD, Ben-Dor E, Michaelis M, Amir R, Devor M. 2000a. Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury. Pain 85:503-521.
129. Liu X, Eschenfelder S, Blenk K, Janig W, Habler H. 2000b. Spontaneous activity of axotomized afferent neurons after L5 spinal nerve injury in rats. Pain 84:309-318.
130. Liu X, Zhou J, Chung K, Chung JM. 2001. Ion channels associated with the ectopic discharges generated after segmental spinal nerve injury in the rat. Brain Res 900:119-127.
131. Mao J, Chen LL. 2000. Systemic lidocaine for neuropathic pain relief. Pain 87:7-17.
132. Marchettini P, Lacerenza M, Marangoni C, Pellegata G, Sotgiu ML, Smirne S. 1992. Lidocaine test in neuralgia. Pain 48:377-382.
133. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. 1997. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 38:859-880.
134. Matzner O, Devor M. 1992. Na+ conductance and the threshold for repetitive neuronal firing. Brain Res 597:92-98.
135. Matzner O, Devor M. 1994. Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na+ channels. J Neurophysiol 72:349-359.
136. McCleane G. 1999. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial. Pain 83:105-107.
137. McCleskey EW, Gold MS. 1999. Ion channels of nociception. Annu Rev Physiol 61:835-856.
138. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. 1995. Anticonvulsant drugs for management of pain: a systematic review. Br Med J 311:1047-1052.
139. Merighi A, Carmignoto G, Gobbo S, Lossi L, Salio C, Vergnano AM, Zonta M. 2004. Neurotrophins in spinal cord nociceptive pathways. Prog Brain Res 146:291-321.
140. Morgan K, Stevens EB, Shah B, Cox PJ, Dixon AK, Lee K, Pinnock RD, Hughes J, Richardson PJ, Mizuguchi K, Jackon AP. 2000. Beta 3: An additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci USA 97:2308-2313.
141. Na HS, Ko KH, Back SK, Sung B, Yoo DJ, Hong SK. 2000. Role of signals from the dorsal root ganglion in neuropathic pain in a rat model. Neurosci Lett 288:147-150.
142. Nagaro T, Shimizu C, Inoue H, Fujitani T, Adachi N, Amakawa K, Kimura S, Arai T, Watanabe T, Oka S. 1995. The efficacy of intravenous lidocaine on various types of neuropathic pain. Masui 44:862-867 (article translated from Japanese).
143. Nakamura-Craig M, Follenfant RL. 1995. Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain 63:33-37.
144. Nau C, Wang SY, Strichartz GR, Wang GK. 1999. Point mutations at N434 in D1-S6 of mu1 Na(+) channels modulate binding affinity and stereoselectivity of local anesthetic enantiomers. Mol Pharmacol 56:404-413.
145. Nordin M, Nystrom B, Wallin U, Hagbarth KE. 1984. Ectopic sensory discharges and paresthesiae in patients with disorders of peripheral nerves, dorsal roots and dorsal columns. Pain 20:231-245.
146. Novakovic SD, Tzoumaka E, McGivern JG, Haraguchi M, Sangameswaran L, Gogas KR, Eglen RM, Hunter JC. 1998. Distribution of the tetrodotoxin-resistant sodium channel PN 3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci 18:2174-2187.
147. Nozald-Taguchi N, Chaplan SR, Higuera ES, Ajakwe RC, Yaksh TL. 2001. Vincristine-induced allodynia in the rat. Pain 93:69-76.
148. Nuss HB, Tomaselli GF, Marban E. 1995. Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (mu 1) channels. J Gen Physiol 106:1193-1209.
149. Nuss HB, Kambouris NG, Marbin E, Tomaselli GF, Balser JR. 2000. Isoform-specific lidocaine block of sodium channels explained by differences in gating. Biophys J 78:200-210.
150. Nystrom B, Hagbarth KE. 1981. Microelectrode recordings from transected nerves in amputees with phantom limb pain. Neurosci Lett 27:211-216.
151. Ochoa J, Torebjork HE, Culp WJ, Schady W. 1982. Abnormal spontaneous activity in single sensory nerve fibers in humans. Muscle Nerve 5:S74-S77.
152. Ogata N, Tatebayashi H. 1993. Kinetic analysis of two types of Na+ channels in rat dorsal root ganglia. J Physiol 466:9-37.
153. Oh Y, Waxman SG. 1998. Novel splice variants of the voltage-sensitive sodium channel alpha subunit. Neuroreport 9:1267-1272.
154. Okuse K, Chaplan SR, McMahon SB, Luo ZD, Calcutt NA, Scott BP, Akopian AN, Wood JN. 1997. Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain. Mol Cell Neurosci 10:196-207.
155. Omana-Zapata I, Khabbaz MA, Hunter JC, Bley KR. 1997. QX-314 inhibits ectopic nerve activity associated with neuropathic pain. Brain Res 771:228-237.
156. Pappagallo M. 2003. Newer antiepileptic drugs: Possible uses in the treatment of neuropathic pain and migraine. Clin Ther 25:2506-2538.
157. Persaud N, Strichartz GR. 2002. Micromolar lidocaine selectively blocks propagating ectopic impulses at a distance from their site of origin. Pain 99:333-340.
158. Pertovaara A, Kontinen VK, Kalso EA. 1997. Chronic spinal nerve ligation induces changes in response characteristics of nociceptive spinal dorsal horn neurons and in their descending regulation originating in the periaqueductal gray in the rat. Exp Neurol 147:428-436.
159. Petersen P, Kastrup J, Zeeberg I, Boysen G. 1986. Chronic pain treatment with intravenous lidocaine. Neurol Res 8:189-190.
160. Pezet S, Malcangio M, McMahon SB. 2002. BDNF: a neuromodulator in nociceptive pathways? Brain Res Brain Res Rev 40:240-249.
161. Pitcher GM, Henry JL. 2004. Nociceptive response to innocuous mechanical stimulation is mediated via myelinated afferents and NK-1 receptor activation in a rat model of neuropathic pain. Exp Neurol 186:173-197.
162. Poliak S, Peles E. 2003. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 4:968-980.
163. Porreca F, Lai J, Bian D, Wegert S, Ossipov MH, Eglen RM, Kassotakis L, Novakovic S, Rabert DK, Sangameswaran L, Hunter JC. 1999. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci USA 96:7640-7644.
164. Priest BT, Murphy BA, Lindia JA, Diaz C, Abbadie C, Ritter AM, Liberator P, Iyer LM, Kash SF, Kohler MG, Kaczorowski GJ, MacInryre DE, Martin WJ. 2005. Contribution of the tetrodotox-in-resistant DSvoltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci USA 102:9382-9387.
165. Quasthoff S, Grosskreutz J, Schroder JM, Schneider U, Grafe P. 1995. Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated C fibres of biopsied human sural nerve. Neuroscience 69:955-965.
166. Ragsdale DS, McPhee JC, Scheuer T, Catterall WA. 1994. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science 265:1724-1728.
167. Ragsdale DS, McPhee JC, Scheuer T, Catterall WA. 1996. Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc Natl Acad Sci USA 93:9270-9275.
168. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI. 2004. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63:865-873.
169. Renganathan M, Dib-Hajj S, Waxman SG. 2002. Na(v)1.5 underlies the third TTX-R sodium current' in rat small DRG neurons. Brain Res Mol Brain Res 106:70-82.
170. Rowbotham MC, Reisner-Keller LA, Fields HL. 1991. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41:1024-1028.
171. Rowbotham MC, Davies PS, Fields HL. 1995. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 37:246-253.
172. Roy ML, Narahashi T. 1992. Differential properties of tetrodotorin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. J Neurosci 12:2104-2111.
173. Roza C, Laird JM, Souslova V, Wood JN, Cervero F. 2003. The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol 550:921-926.
174. Rull JA, Quibrera R, Gonzalez-Millan H, Lozano Castaneda O. 1969. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 5:215-218.
175. Rush AM, Brau ME, Elliott AA, Elliott JR. 1998. Electrophysiological properties of sodium current subtypes in small cells from adult rat dorsal root ganglia. J Physiol (Lond). 511:771-789.
176. Sangameswaran L, Delgado SG, Fish LM, Koch BD, Jakeman LB, Stewart GR, Sze P, Hunter JC, Eglen RM, Herman RC. 1996. Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem 271:5953-5956.
177. Sangameswaran L, Fish LM, Koch BD, Rabert DK, Delgado SG, Ilnicka M, Jakeman LB, Novakovic S, Wong K, Sze P and others. 1997. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem 272:14805-14809.
178. Satin J, Kyle JW, Chen M, Bell P, Cribbs LL, Fozzard HA, Rogart RB. 1992. A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties. Science 256:1202-1205.
179. Saudek CD, Werns S, Reidenberg MM. 1977. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 22:196-199.
180. Scholz A, Kuboyama N, Hempelmann G, Vogel W. 1998. Complex blockade of TTX-resistant Na+ currents by lidocaine and bupivacaine reduce firing frequency in DRG neurons. J Neurophysiol 79:1746-1754.
181. Sheen K, Chung JM. 1993. Signs of neuropathic pain depend on signals from injured nerve fibers in a rat model. Brain Res 610:62-68.
182. Shembalkar PK, Till S, Boettger MK, Terenghi G, Tate S, Bountra C, Anand P. 2001. Increased sodium channel SNS/PN3 immunoreactivity in a causalgic finger. Eur J Pain 5:319-323.
183. Simpson DM, McArthur JC, Obey R, Clifford D, So Y, Ross D, Baird BJ, Barrett P, Hammer AE. 2003. Lamotrigine for HIV-associated painful sensory neuropathies: A placebo-controlled trial. Neurology 60:1508-1514.
184. Sinnott C, Edmonds P, Cropley I, Hanks G, Dunlop RJ. 1991. Flecainide in cancer nerve pain. Lancet 337:1347.
185. Sleeper AA, Cummins TR, Dib-Hajj SD, Hormuzdiar W, Tyrrell L, Waxman SG, Black JA. 2000. Changes in expression of two tetrodotoxin-resistant sodium channels and their currents in dorsal root ganglion neurons after sciatic nerve injury but not rhizotomy. J Neurosci 20:7279-7289.
186. Smith LJ, Shih A, Miletic G, Miletic V. 2002. Continual systemic infusion of lidocaine provides analgesia in an animal model of neuropathic pain. Pain 97:267-273.
187. Stebbing MJ, Eschenfelder S, Habler HJ, Acosta MC, Janig W, McLachlan EM. 1999. Changes in the action potential in sensory neurones after peripheral axotomy in vivo. Neuroreport 10:201-206.
188. Strassman AM, Raymond SA. 1999. Electrophysiological evidence for tetrodotoxin-resistant sodium channels in slowly conducting dural sensory fibers. J Neurophysiol 81:413-424.
189. Sukhotinsky I, Ben-Dor E, Raber P, Devor M. 2004. Key role of the dorsal root ganglion in neuropathic tactile hypersensibility. Eur J Pain 8:135-143.
190. Suzuki R, Kontinen VK, Matthews E, Williams E, Dickenson AH. 2000. Enlargement of the receptive field size to low intensity mechanical stimulation in the rat spinal nerve ligation model of neuropathy. Exp Neurol 163:408-413.
191. Takahashi N, Kikuchi S, Dai Y, Kobayashi K, Fukuoka T, Noguchi K. 2003. Expression of auxiliary beta subunits of sodium channels in primary afferent neurons and the effect of nerve injury. Neuroscience 121:441-450.
192. Tal M, Wall PD, Devor M. 1999. Myelinated afferent fiber types that become spontaneously active and mechanosensitive following nerve transection in the rat. Brain Res 824:218-223.
193. Tanaka M, Cummins TR, Ishikawa K, Dib-Hajj SD, Black JA, Waxman SG. 1998. SNS Na+ channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model. Neuroreport 9:967-972.
194. Tanelian DL, Brose WG. 1991. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 74:949-951.
195. Tanelian DL, Victory RA. 1995. Sodium channel-blocking agents: their use in neuropathic pain conditions. Pain Forum 4:75-80.
196. Tate S, Benn S, Hick C, Trezise D, John V, Mannion RJ, Costigan M, Plumpton C, Grose D, Gladwell Z, Kendall G, Dale K, Bountra C, Woolf CJ. 1998. Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons. Nat Neurosci 1:653-655.
197. Thienel U, Neto W, Schwabe SK, Vijapurkar U. 2004. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 110:221-231.
198. Toledo-Aral JJ, Moss BL, He ZJ, Koszowski AG, Whisenand T, Levinson SR, Wolf JJ, Silos-Santiago I, Halegoua S, Mandel G. 1997. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci USA 94:1527-1532.
199. Torebjork E. 1993. Human microneurography and intraneural microstimulation in the study of neuropathic pain. Muscle Nerve 16:1063-1065.
200. Torebjork HE, Ochoa JL, McCann FV. 1979. Paresthesiae: abnormal impulse generation in sensory nerve fibres in man. Acta Physiol Scand 105:518-520.
201. Tremont-Lukats IW, Megeff C, Backonja MM. 2000. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 60:1029-1052.
202. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. 2001. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 56:184-190.
203. R. Recept Chann 10:11-23.
204. Wall PD, Gutnick M. 1974. Ongoing activity in peripheral nerves: The physiology and pharmacology of impulses originating from a neuroma. Exp Neurol 43:580-593.
205. Wallace MS, Ridgeway BM, Leung AY, Gerayli A, Yaksh TL. 2000. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology 92:75-83.
206. Waxman SG, Ritchie JM. 1985. Organization of ion channels in the myelinated nerve fiber. Science 228:1502-1507.
207. Waxman SG, Kocsis JD, Black JA. 1994. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 72:466-470.
208. Weiser T, Qu Y, Catterall WA, Scheuer T. 1999. Differential interaction of R-mexiletine with the local anesthetic receptor site on brain and heart sodium channel alpha-subunits. Mol Pharmacol 56:1238-1244.
209. Welk E, Leah JD, Zimmermann M. 1990. Characteristics of A- and C-fibers ending in a sensory nerve neuroma in the rat. J Neurophysiol 63:759-766.
210. Willow M, Gonoi T, Catterall WA. 1985. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol Pharmacol 27:549-558.
211. Wood JN, Akopian AN, Baker M, Ding Y, Geoghegan F, Nassar M, Malik-Hall M, Okuse K, Poon L, Ravenall S, Sukumaran M, Souslova V. 2002. Sodium channels in primary sensory neurons: relationship to pain states. Novartis Found Symp 241:159-168; discussion 168-172, 226-232.
212. Woolf CJ. 1983. Evidence for a central component of post-injury pain hypersensitivity. Nature 306:686-688.
213. Woolf CJ. 1993. The pathophysiology of peripheral neuropathic pain-abnormal peripheral input and abnormal central processing. Acta Neurochir Suppl (Wien) 58:125-130.
214. + channel D4-S6 reduce inactivated channel block by local anesthetics. Mol Pharmacol 54:733-739.
215. Wu G, Ringkamp M, Hartke TV, Murinson BB, Campbell JN, Griffin JW, Meyer RA. 2001. Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J Neurosci 21:RC140.
216. Wu G, Ringkamp M, Murinson BB, Pogatzki EM, Hartke TV, Weerahandi HM, Campbell JN, Griffin JW, Meyer RA. 2002. Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fiber afferents. J Neurosci 22:7746-7753.
217. Yang Y, Wang Y, Li S, Xu Z, Li H, Ma L, Fan J, Bu D, Liu B, Fan Z, Wu G, Jin J, Ding B, Zhu X, Shen Y. 2004. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 41:171-174.
218. Yates JM, Smith KG, Robinson PP. 2000. Ectopic neural activity from myelinated afferent fibres in the lingual nerve of the ferret following three types of injury. Brain Res 874:37-47.
219. Yiangou Y, Birch R, Sangameswaran L, Eglen R, Anand P. 2000. SNS/PN3 and SNS2/NaN sodium channel-like immunoreactivity in human adult and neonate injured sensory nerves. FEBS Lett 467:249-252.
220. Yoon YW, Na HS, Chung JM. 1996. Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain 64:27-36.
221. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. 1997. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73:223-230.